RNA targeting and translation in axons.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Exploration of biomaterial and stem cell-based strategies for promoting neuronal regeneration and creating engineered 3D in-vitro disease models.Journal of translational medicine · 2025
   Review
2. Diabetic neuropathy: cutting-edge research and future directions.Signal transduction and targeted therapy · 2025
   Review
3. Spinal cord injury regulates circular RNA expression in axons.Frontiers in molecular neuroscience · 2023
   Article
4. Distinct small non-coding RNA landscape in the axons and released extracellular vesicles of developing primary cortical neurons and the axoplasm of adult nerves.RNA biology · 2021
   Article
5. Mechanisms of neurite repair.Current opinion in neurobiology · 2020
   Review
6. Regulation of NGF Signaling by an Axonal Untranslated mRNA.Neuron · 2019
   Article
7. AnBiology open · 2018
   Article

Corrections and comments

• Comment on
  Locally translated mTOR controls axonal local translation in nerve injury.2018

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as